|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
2
|
Cho HJ, Kang JH, Kwak JY, et al:
Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9
gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent
mechanisms. Carcinogenesis. 28:1104–1110. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang X, Lu H, Urvalek AM, et al: KLF8
promotes human breast cancer cell invasion and metastasis by
transcriptional activation of MMP9. Oncogene. 30:1901–1911. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yan C and Boyd DD: Regulation of matrix
metalloproteinase gene expression. J Cell Physiol. 211:19–26. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nagase H and Woessner JF Jr: Matrix
metalloproteinases. J Biol Chem. 274:21491–21494. 1999. View Article : Google Scholar
|
|
6
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Scorilas A, Karameris A, Arnogiannaki N,
et al: Overexpression of matrix-metalloproteinase-9 in human breast
cancer: a potential favourable indicator in node-negative patients.
Br J Cancer. 84:1488–1496. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nabeshima K, Inoue T, Shimao Y and
Sameshima T: Matrix metalloproteinases in tumor invasion: role for
cell migration. Pathol Int. 52:255–264. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bailly C: Topoisomerase I poisons and
suppressors as anticancer drugs. Curr Med Chem. 7:39–58. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Masuda Y, Nishida A, Hori K, et al:
β-hydroxyisovaleryl shikonin induces apoptosis in human leukemia
cells by inhibiting the activity of a polo-like kinase 1 (PLK1).
Oncogene. 22:1012–1023. 2003.
|
|
13
|
Kim SH, Kang IC, Yoon TJ, et al: Antitumor
activities of a newly synthesized shikonin derivative,
2-hyim-DMNQ-S-33. Cancer Lett. 172:171–175. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Masuda Y, Shima G, Aiuchi T, et al:
Involvement of tumor necrosis factor receptor-associated protein 1
(TRAP1) in apoptosis induced by β-hydroxyisovalerylshikonin. J Biol
Chem. 279:42503–42515. 2004.PubMed/NCBI
|
|
15
|
Yoon Y, Kim YO, Lim NY, Jeon WK and Sung
HJ: Shikonin, an ingredient of Lithospermum erythrorhizon
induced apoptosis in HL60 human premyelocytic leukemia cell line.
Planta Med. 65:532–535. 1999.
|
|
16
|
Yang H, Zhou P, Huang H, et al: Shikonin
exerts antitumor activity via proteasome inhibition and cell death
induction in vitro and in vivo. Int J Cancer.
124:2450–2459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gaddipati JP, Mani H, Shefali, et al:
Inhibition of growth and regulation of IGFs and VEGF in human
prostate cancer cell lines by shikonin analogue 93/637 (SA).
Anticancer Res. 20:2547–2552. 2000.PubMed/NCBI
|
|
18
|
Wu Z, Wu L, Li L, Tashiro S, Onodera S and
Ikejima T: p53-mediated cell cycle arrest and apoptosis induced by
shikonin via a caspase-9-dependent mechanism in human malignant
melanoma A375–S2 cells. J Pharmacol Sci. 94:166–176.
2004.PubMed/NCBI
|
|
19
|
Chung TW, Moon SK, Chang YC, et al: Novel
and therapeutic effect of caffeic acid and caffeic acid phenyl
ester on hepatocarcinoma cells: complete regression of hepatoma
growth and metastasis by dual mechanism. FASEB J. 18:1670–1681.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu B, Thirtamara-Rajamani KK, Sim H and
Viapiano MS: Fibulin-3 is uniquely upregulated in malignant gliomas
and promotes tumor cell motility and invasion. Mol Cancer Res.
7:1756–1770. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang W, Yu LF, Zhong J, et al:
Angiotensin II type 1 receptor expression in human gastric cancer
and induces MMP2 and MMP9 expression in MKN-28 cells. Dig Dis Sci.
53:163–168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin H, Pan Y, He L, et al: p75
neurotrophin receptor inhibits invasion and metastasis of gastric
cancer. Mol Cancer Res. 5:423–433. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Min R, Zun Z, Min Y, Wenhu D, Wenjun Y and
Chenping Z: Shikonin inhibits tumor invasion via down-regulation of
NF-κB-mediated MMP-9 expression in human ACC-M cells. Oral Dis.
17:362–369. 2011.PubMed/NCBI
|
|
24
|
Sato T, Koike L, Miyata Y, et al:
Inhibition of activator protein-1 binding activity and
phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy
flavonoid, results in augmentation of tissue inhibitor of
metalloproteinases-1 production and suppression of production of
matrix metalloproteinases-1 and −9 in human fibrosarcoma HT-1080
cells. Cancer Res. 62:1025–1029. 2002.PubMed/NCBI
|
|
25
|
Gum R, Lengyel E, Juarez J, et al:
Stimulation of 92-kDa gelatinase B promoter activity by ras is
mitogen-activated protein kinase kinase 1-independent and requires
multiple transcription factor binding sites including closely
spaced PEA3/ets and AP-1 sequences. J Biol Chem. 271:10672–10680.
1996. View Article : Google Scholar
|
|
26
|
Yokoo T and Kitamura M: Dual regulation of
IL-1 beta-mediated matrix metalloproteinase-9 expression in
mesangial cells by NF-kappa B and AP-1. Am J Physiol.
270:F123–F130. 1996.PubMed/NCBI
|
|
27
|
Matthews CP, Colburn NH and Young MR: AP-1
a target for cancer prevention. Curr Cancer Drug Targets.
7:317–324. 2007. View Article : Google Scholar
|
|
28
|
Milde-Langosch K: The Fos family of
transcription factors and their role in tumourigenesis. Eur J
Cancer. 41:2449–2461. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ozanne BW, Spence HJ, McGarry LC and
Hennigan RF: Transcription factors control invasion: AP-1 the first
among equals. Oncogene. 26:1–10. 2007. View Article : Google Scholar : PubMed/NCBI
|
